{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "52027844",
    "licUnit": "1",
    "validDate": "2025-03-23 00:00:00.000",
    "issueDate": "2020-03-23 00:00:00.000",
    "oriIssueDate": null,
    "licKind": "10",
    "oldLicid": null,
    "certNo": null,
    "prodNameC": "伯替唑他",
    "prodNameE": "Brotizolam",
    "indicationsName": [
        "失眠症的治療"
    ],
    "does": "0042",
    "packageUnit": [
        {
            "packageSpec": "",
            "packageUnit": "44"
        }
    ],
    "medMCode": "01",
    "maMedCode": "D",
    "medDCode": "E",
    "mainCategory": "E",
    "drBaseId": "53998A6A-43F0-4121-A854-7682C4E0C6D2",
    "subCategory": [],
    "ingredientsDesc": [
        "Brotizolam contains not less than 99.0% and not more than 101.0% of C15H10BrClN4S, calculated on the anhydrous basis."
    ],
    "restraintItemsCode": [
        "02",
        "06",
        "34"
    ],
    "applicantName": "宇直泰貿易股份有限公司",
    "applicantAddr": "台北市中山區南京東路二段206號8樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "id": "6E3A8959-0AD4-4FF8-82B0-A56A9ACAB38B",
            "factoryCode": "1",
            "factoryName": "CENTAUR PHARMACEUTICALS PVT. LTD.",
            "factoryAddr": "Plot No. 75, 76& 76\/1 & 74 Chikhloli M.I.D.C. Ambernath (West), India-421 501 Thane, Maharashtra",
            "factoryCompanyAddr": "",
            "countryCode": "IN",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FIN0075200",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": null,
            "ingredientsName": "Brotizolam contains not less than 99.0% and not more than 101.0% of C15H10BrClN4S, calculated on the anhydrous basis.",
            "ingredientsDesc": "Brotizolam contains not less than 99.0% and not more than 101.0% of C15H10BrClN4S, calculated on the anhydrous basis.",
            "concentDesc": null,
            "concent": null,
            "concentUnit": null,
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "2"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [],
    "licBaseId": "B394A9AD-EB41-4A3D-8865-5C8502888983"
}